Literature DB >> 17595217

Sex differences in endothelial STAT3 mediate sex differences in myocardial inflammation.

Meijing Wang1, Wenjun Zhang, Paul Crisostomo, Troy Markel, Kirstan K Meldrum, Xin Y Fu, Daniel R Meldrum.   

Abstract

Recent studies have shown that females have improved myocardial functional recovery, TNF receptor 1 (TNFR1) signaling resistance, and increased STAT3 phosphorylation following acute ischemia/reperfusion (I/R) compared with males. We hypothesized that 1) STAT3 deficiency in endothelial cells (EC) impairs myocardial functional recovery in both sexes, 2) EC STAT3 deficiency equalizes sex differences in functional recovery, and 3) knockout of EC STAT3 decreases activation of myocardial STAT3 and increases p38 MAPK activation following acute I/R. Isolated male and female mouse hearts from WT and EC STAT3 knockout (STAT3KO) were subjected to 20-min ischemia/60-min reperfusion, and +/- dP/dt were continuously recorded. Heart tissue was analyzed for the active forms of STAT3 and p38 MAPK as well as expression of caspase-8 (Western blot) following I/R. EC STATKO had significantly decreased myocardial functional recovery in both sexes (%recovered +dP/dt: male 51.6 +/- 3.1 vs. 32.1 +/- 13.1%, female 79.1 +/- 3.6 vs. 43.6 +/- 9.1%; -dP/dt: male 52.2 +/- 3.3 vs. 28.9 +/- 12%, female 75.2 +/- 4.1 vs. 38.6 +/- 10%). In addition, EC STAT3KO neutralized sex differences in myocardial function, which existed in WT mice. Interestingly, EC STAT3 deficiency decreased myocardial STAT3 activation but increased myocardial p38 MAPK activation in both sexes; however, this was seen to a greater degree in females. We conclude that EC STAT3 deficiency resulted in decreased recovery of myocardial function in both sexes and neutralized sex differences in myocardial functional recovery following I/R. This observation was associated with decreased activation of myocardial STAT3 and increased activation of p38 MAPK in EC STAT3KO heart after I/R.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17595217     DOI: 10.1152/ajpendo.00251.2007

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  7 in total

1.  Both endogenous and exogenous testosterone decrease myocardial STAT3 activation and SOCS3 expression after acute ischemia and reperfusion.

Authors:  Meijing Wang; Yue Wang; Aaron Abarbanell; Jiangjing Tan; Brent Weil; Jeremy Herrmann; Daniel R Meldrum
Journal:  Surgery       Date:  2009-06-25       Impact factor: 3.982

2.  Youth with type 1 diabetes have worse strain and less pronounced sex differences in early echocardiographic markers of diabetic cardiomyopathy compared to their normoglycemic peers: A RESistance to InSulin in Type 1 ANd Type 2 diabetes (RESISTANT) Study.

Authors:  Petter Bjornstad; Uyen Truong; Laura Pyle; Jennifer L Dorosz; Melanie Cree-Green; Amy Baumgartner; Gregory Coe; Judith G Regensteiner; Jane E B Reusch; Kristen J Nadeau
Journal:  J Diabetes Complications       Date:  2016-04-13       Impact factor: 2.852

Review 3.  Matters of the heart: Cellular sex differences.

Authors:  Cierra J Walker; Megan E Schroeder; Brian A Aguado; Kristi S Anseth; Leslie A Leinwand
Journal:  J Mol Cell Cardiol       Date:  2021-06-22       Impact factor: 5.763

4.  Acyloxy nitroso compounds inhibit LIF signaling in endothelial cells and cardiac myocytes: evidence that STAT3 signaling is redox-sensitive.

Authors:  Carlos Zgheib; Mazen Kurdi; Fouad A Zouein; Barak W Gunter; Brian A Stanley; Joe Zgheib; Damian G Romero; S Bruce King; Nazareno Paolocci; George W Booz
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

5.  Molecular sex differences in human serum.

Authors:  Jordan M Ramsey; Emanuel Schwarz; Paul C Guest; Nico J M van Beveren; F Markus Leweke; Matthias Rothermundt; Bernhard Bogerts; Johann Steiner; Liliana Ruta; Simon Baron-Cohen; Sabine Bahn
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

6.  Cardiac preconditioning with sphingosine-1-phosphate requires activation of signal transducer and activator of transcription-3.

Authors:  Roisin F Kelly-Laubscher; Jonathan C King; Damian Hacking; Sarin Somers; Samantha Hastie; Tessa Stewart; Aqeela Imamdin; Gerald Maarman; Sarah Pedretti; Sandrine Lecour
Journal:  Cardiovasc J Afr       Date:  2014 May-Jun       Impact factor: 1.167

Review 7.  The roles of signal transducer and activator of transcription factor 3 in tumor angiogenesis.

Authors:  Peng Gao; Na Niu; Tianshu Wei; Hideto Tozawa; Xiaocui Chen; Caiqing Zhang; Jiandong Zhang; Youichiro Wada; Carolyn M Kapron; Ju Liu
Journal:  Oncotarget       Date:  2017-08-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.